Paul Juniewicz, Ph.D.

Dr. Juniewicz serves as Senior Advisor with Outcome Capital’s Biotechnology and Pharma practices. He brings extensive scientific, strategic and operational expertise in public and private life science companies.

He is currently Senior Director of Business Development at Takeda Pharmaceuticals Oncology Business Unit focusing on late-stage clinical oncology opportunities. Prior to that, Dr. Juniewicz served as Senior Director for Oncology Search & Evaluation in Takeda’s Center for External Innovation (CEI). In this role, he led the scouting of external oncology opportunities as well scientific and technical due diligence for several transactions including, among others, MD Anderson, Turnstone Biologics, Memorial Sloan Kettering Cancer Center, Shattuck Labs, Molecular Templates, Maverick Therapeutics, as well as the Japan licensing of cabozantinib (Exelixis) and niraparib (Tesaro) and the merger and acquisition of Ariad Pharmaceuticals. Based on his accomplishments Paul was awarded the title of Distinguished Research Fellow in Oncology in 2019.

Dr. Juniewicz started his professional career with Sterling Drug as a bench research scientist and then took a position as Oncology Project Manager overseeing several oncology projects. Following the acquisition of Sterling Drug by Sanofi, Paul rose to the role of VP Oncology Project Management and oversaw the development of oncology projects that resulted in global regulatory approvals for several agents including oxaliplatin for colorectal cancer, rasburicase for tumor lysis syndrome and aflibercept for colorectal cancer.

Dr. Juniewicz numerous accomplishments include over 100 external opportunities reviewed with 10+ entering due diligences each year, development of Takeda’s oncology strategy, oncology scouting and partnering activities at AACR, ASCO & ASH, JP Morgan and BIO meetings.

Dr. Juniewicz received a BS from Rutgers University, an MS and a Ph.D. from North Carolina State University. He completed his postdoctoral training at Johns Hopkins University.